BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 38954793)

  • 1. A 3-Times-Daily Dosing Scheme of Prazosin to Treat Posttraumatic Stress Disorder-Induced Psychological Distress in the Hospital.
    Tucker KJ; Villanueva TT; Fletcher M; Putnam K; Herink MC
    Prim Care Companion CNS Disord; 2024 Jun; 26(3):. PubMed ID: 38954793
    [No Abstract]   [Full Text] [Related]  

  • 2. Refractory nightmares in post-traumatic stress disorder: remission with prazosin.
    Muquebil Ali Al Shaban-Rodríguez OW; Álvarez-Mazariegos JA; Díaz-Díez V; Tuñón-Gorgojo L
    Actas Esp Psiquiatr; 2019 May; 47(3):121-6. PubMed ID: 31233210
    [No Abstract]   [Full Text] [Related]  

  • 3. Early discontinuation and suboptimal dosing of prazosin: a potential missed opportunity for veterans with posttraumatic stress disorder.
    Alexander B; Lund BC; Bernardy NC; Christopher ML; Friedman MJ
    J Clin Psychiatry; 2015 May; 76(5):e639-44. PubMed ID: 26035198
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting the Noradrenergic System in Posttraumatic Stress Disorder: A Systematic Review and Meta-Analysis of Prazosin Trials.
    De Berardis D; Marini S; Serroni N; Iasevoli F; Tomasetti C; de Bartolomeis A; Mazza M; Tempesta D; Valchera A; Fornaro M; Pompili M; Sepede G; Vellante F; Orsolini L; Martinotti G; Di Giannantonio M
    Curr Drug Targets; 2015; 16(10):1094-106. PubMed ID: 25944011
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Expanded usage of prazosin in pre-pubertal children with nightmares resulting from posttraumatic stress disorder.
    Racin PR; Bellonci C; Coffey DB
    J Child Adolesc Psychopharmacol; 2014 Oct; 24(8):458-61. PubMed ID: 25299588
    [No Abstract]   [Full Text] [Related]  

  • 6. Terazosin for the treatment of trauma-related nightmares: a report of 4 cases.
    Nirmalani-Gandhy A; Sanchez D; Catalano G
    Clin Neuropharmacol; 2015; 38(3):109-11. PubMed ID: 25970279
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Trial of Prazosin for Post-Traumatic Stress Disorder in Military Veterans.
    Raskind MA; Peskind ER; Chow B; Harris C; Davis-Karim A; Holmes HA; Hart KL; McFall M; Mellman TA; Reist C; Romesser J; Rosenheck R; Shih MC; Stein MB; Swift R; Gleason T; Lu Y; Huang GD
    N Engl J Med; 2018 Feb; 378(6):507-517. PubMed ID: 29414272
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Pretreatment Blood Pressure Is Associated With Greater Posttraumatic Stress Disorder Symptom Reduction in Soldiers Treated With Prazosin.
    Raskind MA; Millard SP; Petrie EC; Peterson K; Williams T; Hoff DJ; Hart K; Holmes H; Hill J; Daniels C; Hendrickson R; Peskind ER
    Biol Psychiatry; 2016 Nov; 80(10):736-742. PubMed ID: 27320368
    [TBL] [Abstract][Full Text] [Related]  

  • 9. A pilot trial of prazosin, an alpha-1 adrenergic antagonist, for comorbid alcohol dependence and posttraumatic stress disorder.
    Simpson TL; Malte CA; Dietel B; Tell D; Pocock I; Lyons R; Varon D; Raskind M; Saxon AJ
    Alcohol Clin Exp Res; 2015 May; 39(5):808-17. PubMed ID: 25827659
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A Pilot, Randomized Clinical Trial of Bedtime Doses of Prazosin Versus Placebo in Suicidal Posttraumatic Stress Disorder Patients With Nightmares.
    McCall WV; Pillai A; Case D; McCloud L; Nolla T; Branch F; Youssef NA; Moraczewski J; Tauhidul L; Pandya CD; Rosenquist PB
    J Clin Psychopharmacol; 2018 Dec; 38(6):618-621. PubMed ID: 30335633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prazosin for Veterans with Posttraumatic Stress Disorder and Comorbid Alcohol Dependence: A Clinical Trial.
    Petrakis IL; Desai N; Gueorguieva R; Arias A; O'Brien E; Jane JS; Sevarino K; Southwick S; Ralevski E
    Alcohol Clin Exp Res; 2016 Jan; 40(1):178-86. PubMed ID: 26683790
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Re-emergence of posttraumatic stress disorder nightmares with nursing home admission: treatment with prazosin.
    Johnson KG; Rosen J
    J Am Med Dir Assoc; 2013 Feb; 14(2):130-1. PubMed ID: 23141208
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prazosin for trauma-related nightmares in civilians at a Singapore hospital: a case series.
    Soh KC; Tay YH
    East Asian Arch Psychiatry; 2024 Mar; 34(1):14-17. PubMed ID: 38955779
    [No Abstract]   [Full Text] [Related]  

  • 14. Alcohol Abstainer Status and Prazosin Treatment in Association with Changes in Posttraumatic Stress Disorder Symptoms in Veterans with Comorbid Alcohol Use Disorder and Posttraumatic Stress Disorder.
    Verplaetse TL; Ralevski E; Roberts W; Gueorguieva R; McKee SA; Petrakis IL
    Alcohol Clin Exp Res; 2019 Apr; 43(4):741-746. PubMed ID: 30698839
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prazosin in the treatment of PTSD.
    Green B
    J Psychiatr Pract; 2014 Jul; 20(4):253-9. PubMed ID: 25036580
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prazosin reduces trauma-related nightmares in older men with chronic posttraumatic stress disorder.
    Peskind ER; Bonner LT; Hoff DJ; Raskind MA
    J Geriatr Psychiatry Neurol; 2003 Sep; 16(3):165-71. PubMed ID: 12967060
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Clinical Use of Prazosin in a Patient With Acute Stress Disorder: A Case Report.
    Srivastava AA; Opler DJ
    J Psychiatr Pract; 2020 May; 26(3):246-248. PubMed ID: 32421296
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychopharmacologic treatment of dissociative fugue and PTSD in an Ethiopian refugee.
    Liu-Barbaro D; Stein M
    J Clin Psychiatry; 2015 Jul; 76(7):958. PubMed ID: 26115334
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Alpha-1 adrenergic antagonists use increases the risk of sleep apnea: implications for understanding the role of prazosin in posttraumatic stress syndrome.
    McCall WV
    J Clin Sleep Med; 2020 Apr; 16(4):643. PubMed ID: 32022675
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Double-Blind Randomized Clinical Trial of Prazosin for Alcohol Use Disorder.
    Simpson TL; Saxon AJ; Stappenbeck C; Malte CA; Lyons R; Tell D; Millard SP; Raskind M
    Am J Psychiatry; 2018 Dec; 175(12):1216-1224. PubMed ID: 30153753
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.